Self-assembled rosette nanotubes for incorporating hydrophobic drugs in physiological environments

International Journal of Nanomedicine

Volumn 6, Issue 1, 2011, Pages 101-107

  Song, Shang ^a   Chen, Yupeng ^a,b   Yan, Zhimin ^d   Fenniri, Hicham ^d,e   Webster, Thomas J ^a,c  

^a Brown University   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Drug delivery; Rosette nanotubes; Self assembly; Tamoxifen

Indexed keywords

NANOTUBE; ROSETTE NANOTUBE; TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; BIOCOMPATIBILITY; DIFFUSION ORDERED NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; DRUG DELIVERY SYSTEM; HYDROPHILICITY; HYDROPHOBICITY; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; SOLUBILITY; ULTRAVIOLET VISIBLE SPECTROSCOPY;

ANTINEOPLASTIC AGENTS, HORMONAL; DRUG DELIVERY SYSTEMS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICROSCOPY, ATOMIC FORCE; NANOTUBES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PARTICLE SIZE; TAMOXIFEN;

EID: 79251499256     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S11957     Document Type: Article

References (28)

1. Guo W, Huang K, Tang R, Xu H. Synthesis, characterization of novel injectable drug carriers and the antitumor efficacy in mice bearing sarcoma-180 tumor. J Control Release. 2005;107:513-522.
2. Guo W, Shi Z, Liang K, Chen X, Li W. Polyanhydride modified unsaturated polyesters as injectable drug carriers: Synthesis and antitumor efficacy in sarcoma-180 mice bearing tumor. Polym Degrad Stabil. 2006;91:2924-2930.
3. Guo W, Shi Z, Liang K, Liu Y, Chen X, Li W. New unsaturated polyesters as injectable drug carriers. Polym Degrad Stabil. 2007;92:407-413.
4. Kakinoki S, Taguchi T, Saito H, Tanaka J, et al. Injectable in situ forming drug delivery system for cancer chemotherapy using a novel tissue adhesive: Characterization and in vitro evaluation. Eur J Pharm Biopharm. 2007;66:383-390.
5. Okino H, Nakayama Y, Tanaka M, et al. In situ hydrogelation of photocurable gelatin and drug release. J Biomed Mater Res. 2002;59: 233-245.
6. TM): Preparation, characterization, in vitro drug release, and pharmacokinetic evaluation. Pharm Dev Technol. 2006;11: 167-177.
7. Jones MC, Leroux JC. Polymeric micelles - a new generation of colloidal drug carriers. Eur J Pharm Biopharm. 1999;48:101-111.
8. Sharifi S, Mirzadeh H, Imani M, et al. Injectable in situ forming drug delivery system based on poly(e-caprolactone fumarate) for tamoxifen citrate delivery: Gelation characteristics, in vitro drug release and anti- cancer evaluation. Biomaterials. 2009;5:1966-1978.
9. Kwon GS, Okano T. Polymeric micelles as new drug the block copolymer, since the auxiliary agents are carriers. Adv Drug Deliv Rev. 1996; 21:107-116.
10. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv Drug Deliv Rev. 2001;47:113-131.
11. Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2001;73:137-172.
12. 4 dumbbell nanoparticles as dualfunctional probes. Angew Chem Int Ed Engl. 2008;47:173-176.
13. Liu HW, Chen CH, Tsai CL, Lin IH, Hsiue GH. Heterobifunctional poly(ethylene glycol)-tethered bone morphogenetic protein-2- stimulated bone marrow mesenchymal stromal cell differentiation and osteogenesis. Tissue Eng. 2007;13:1113-1124.
14. Yang L, Webster TJ. Nanotechnology controlled drug delivery for treating bone diseases. Expert Opin Drug Deliv. 2009;6:851-864.
15. Gindy ME, Prud'homme RK. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opin Drug Deliv. 2009;6:865-878.
16. Chun AL, Moralez JG, Fenniri H, et al. Helical rosette nanotubes: A more effective orthopaedic implant material. Nanotechnology. 2004; 15:S234-S239.
17. Chun AL, Moralez JG, Webster TJ, et al. Helical rosette nanotubes: A biomimetic coating for orthopedics? Biomaterials. 2005;26: 7304-7309.
18. Fenniri H, Mathivanan P, Vidale KL, et al. Helical rosette nanotubes: Design, self-assembly and characterization. J Am Chem Soc. 2001;123: 3854-3855.
19. Moralez JG, Raez J, Yamazaki T, et al. Helical rosette nanotubes with tunable stability and hierarchy. J Am Chem Soc. 2005;127: 8307-8309.
20. Zhang L, Rakotondradany F, Myles AJ, et al. Arginine-glycine-aspartic acid modified rosette nanotube-hydrogel composites for bone tissue engineering. Biomaterials. 2009;30:1309-1320.
21. Zhang L, Chen Y, Rodriguez J, et al. Biomimetic helical rosette nanotubes and nanocrystalline hydroxyapatite coatings on titanium for improving orthopedic implants. Int J Nanomedicine. 2008;3:323-333.
22. Macgregor J, Jordan VC. Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev. 1998;50:151-196.
23. Okada H, Toguchi H. Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Carrier Syst. 1995;12:1-99.
24. Fung LK, Saltzman WM. Polymeric implants for cancer chemotherapy. Adv Drug Deliv Rev. 1997;26:209-230.
25. Bitz C, Doelker E. Influence of the preparation method on residual solvents in biodegradable microspheres. Int J Pharm. 1996;131: 171-181.
26. Li S, Lepage M, Merand Y, Belanger A, Labrie F. Growth inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by controlled-release low-dose medroxyprogesterone acetate. Breast Cancer Res Treat. 1992;24:127-137.
27. Packhaeuser CB, Schnieders J, Oster CG, Kissel T. In situ forming parenteral drug delivery systems: An overview. Eur J Pharm Biopharm. 2004;58:445-455.
28. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolicacid copolymers. Biomaterials. 1996;17:93-102.